THE LATEST NEWS IN CANCER CLINICAL RESEARCH

Joining forces with QUADRAM Institute Bioscience and University of Bristol for the project CALADRIO

Presentation at ESMO Breast Cancer 2021: METALLICA Trial in Progress

ORPHEUS Study: Evaluation of Retifanlimab In Penile Cancer

Results of the KELLY trial

We granted a video interview to PM Farma

Accelerate therapeutic innovation with clinical trials

PECATI: New clinical trial with pembrolizumab and lenvatinib for patients with advanced thymic tumor

PHERGain-2: a study of a new therapeutic strategy to avoid chemotherapy in breast cancer patients

IASLC 2020 World Conference on Lung Cancer: LUPER initiated trial to be presented

Stage I in LUZERN Study completed!

Results of our BIOPER study were presented at SABCS 2020

Final safety results of our PARSIFAL study were presented at SABCS 2020

SABCS 2020: Final results of PARSIFAL and BIOPER clinical trials to be presented

A new milestone achieved in LUZERN Study: 75% recruitment on stage I

COPERNICO Study has reached 29% recruitment

First Patient Enrolled In ZZ-First Study

SEOM 2020: Results from the Spanish cohort of the MEDSIR-sponsored study PARSIFAL

Results of the PARSIFAL study to be presented at the SEOM Conference 2020

First enrollment in the PATHFINDER study

First enrollment in the LUPER study